Follow us on Facebook to receive the latest CMJ content.

Featured Article

6 Oct 2011

Clopidogrel, the thienopyridine anti-platelet agent, is commonly used to prevent clot formation in a number of pro-coagulant conditions such as coronary artery disease, peripheral vascular disease and cerebrovascular disease. Particularly, it is used with success in patients with STEMI and NSTEMI. It can be used as an alternative to aspirin in patients who do not tolerate the drug, and is increasingly used in combination with aspirin for thrombotic prophlyaxis following coronary stenting.

Original Articles and Perspectives

1 Oct 2011

Trauma is the leading cause of death in young adults in the UK with road traffic accidents being the commonest mechanism. Trauma is responsible for a burden of morbidity with socio-economic implications which are often overlooked by the media. It would seem logical to assume that the management protocol for a serious, not uncommon presentation was well established, but this is not the case: the appropriate diagnostic imaging for this patient is a contentious topic.

Clinical Medicine

17 Sep 2011

Reflections on seven weeks spent in a small Christian hospital Fatehpur in Northern India, where one of the many key health issues is the increasing prevalence of alcohol consumption.

Latest News

6 Oct 2011

Wilderness medicine is a growing field, encompassing aspects of pre-hospital care, expedition medicine and extreme physiology. The challenge of working in an emergency scenario with limited resources has relevance for students interested in a vast range of potential careers – including aid and disaster work, A&E, trauma medicine, the military, general practice, sports medicine and working in the developing world. Additionally, the skills of wilderness medicine allow medics to hone their clinical acumen and ability under pressure.

6 Oct 2011

Clopidogrel, the thienopyridine anti-platelet agent, is commonly used to prevent clot formation in a number of pro-coagulant conditions such as coronary artery disease, peripheral vascular disease and cerebrovascular disease. Particularly, it is used with success in patients with STEMI and NSTEMI. It can be used as an alternative to aspirin in patients who do not tolerate the drug, and is increasingly used in combination with aspirin for thrombotic prophlyaxis following coronary stenting.